BIOGEN INC. Earnings Per Share (Basic)
BIOGEN INC. (BIIB) reported Earnings Per Share (Basic) of $2.17 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-04-29
- BIOGEN INC. earnings per share, basic for the quarter ending 2026-03-31 was $2.17, a 31.52% increase year-over-year.
- BIOGEN INC. earnings per share, basic for the quarter ending 2025-09-30 was $3.18, a 19.10% increase year-over-year.
- BIOGEN INC. earnings per share, basic for the quarter ending 2025-06-30 was $4.33, a 7.98% increase year-over-year.
- BIOGEN INC. earnings per share, basic for the quarter ending 2025-03-31 was $1.65, a 39.11% decline year-over-year.
- BIOGEN INC. earnings per share, basic for fiscal 2025 was $8.83, a 21.23% decline from fiscal 2024.
- BIOGEN INC. earnings per share, basic for fiscal 2024 was $11.21, a 39.78% increase from fiscal 2023.
- BIOGEN INC. earnings per share, basic for fiscal 2023 was $8.02, a 61.74% decline from fiscal 2022.
- BIOGEN INC. earnings per share, basic for fiscal 2022 was $20.96, a 100.77% increase from fiscal 2021.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-03-31 | $2.17 10-Q · filed 2026-04-29 | |||
| 2025-12-31 | $8.83 10-K · filed 2026-02-06 | |||
| 2025-09-30 | $3.18 10-Q · filed 2025-10-30 | $9.16 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | $4.33 10-Q · filed 2025-07-31 | $5.98 10-Q · filed 2025-07-31 | ||
| 2025-03-31 | $1.65 10-Q · filed 2026-04-29 | |||
| 2024-12-31 | $11.21 10-K · filed 2026-02-06 | |||
| 2024-09-30 | $2.67 10-Q · filed 2025-10-30 | $9.38 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | $4.01 10-Q · filed 2025-07-31 | $6.72 10-Q · filed 2025-07-31 | ||
| 2024-03-31 | $2.71 10-Q · filed 2025-05-01 | |||
| 2023-12-31 | $8.02 10-K · filed 2026-02-06 | |||
| 2023-09-30 | -$0.47 10-Q · filed 2024-10-30 | $6.30 10-Q · filed 2024-10-30 | ||
| 2023-06-30 | $4.09 10-Q · filed 2024-08-01 | $6.78 10-Q · filed 2024-08-01 | ||
| 2023-03-31 | $2.69 10-Q · filed 2024-04-24 | |||
| 2022-12-31 | $20.96 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $7.86 10-Q · filed 2023-11-08 | $17.12 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $7.25 10-Q · filed 2023-07-25 | $9.30 10-Q · filed 2023-07-25 | ||
| 2022-03-31 | $2.06 10-Q · filed 2023-04-25 | |||
| 2021-12-31 | $10.44 10-K · filed 2024-02-14 | |||
| 2021-09-30 | $2.22 10-Q · filed 2022-10-25 | $7.93 10-Q · filed 2022-10-25 | ||
| 2021-06-30 | $3.00 10-Q · filed 2022-07-20 | $5.70 10-Q · filed 2022-07-20 | ||
| 2021-03-31 | $2.70 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $2.33 10-K · filed 2021-02-03 | $24.86 10-K · filed 2023-02-15 | ||
| 2020-09-30 | $4.47 10-Q · filed 2021-10-20 | $22.29 10-Q · filed 2021-10-20 | ||
| 2020-06-30 | $9.60 10-Q · filed 2021-07-22 | $17.65 10-Q · filed 2021-07-22 | ||
| 2020-03-31 | $8.10 10-Q · filed 2021-04-22 | |||
| 2019-12-31 | $8.10 10-K · filed 2021-02-03 | $31.47 10-K · filed 2022-02-03 | ||
| 2019-09-30 | $8.40 10-K · filed 2021-02-03 | $23.38 10-Q · filed 2020-10-21 | ||
| 2019-06-30 | $7.85 10-K · filed 2021-02-03 | $15.01 10-Q · filed 2020-07-22 | ||
| 2019-03-31 | $7.17 10-K · filed 2021-02-03 | |||
| 2018-12-31 | $4.74 10-K · filed 2020-02-06 | $21.63 10-K · filed 2021-02-03 | ||
| 2018-09-30 | $7.17 10-K · filed 2020-02-06 | $16.86 10-Q · filed 2019-10-22 | ||
| 2018-06-30 | $4.18 10-K · filed 2020-02-06 | $9.75 10-Q · filed 2019-07-24 | ||
| 2018-03-31 | $5.55 10-K · filed 2020-02-06 | |||
| 2017-12-31 | -$1.41 10-K · filed 2019-02-06 | $11.94 10-K · filed 2020-02-06 | ||
| 2017-09-30 | $5.80 10-K · filed 2019-02-06 | $13.32 10-Q · filed 2018-10-23 | ||
| 2017-06-30 | $4.07 10-K · filed 2019-02-06 | $7.53 10-Q · filed 2018-07-24 | ||
| 2017-03-31 | $3.47 10-K · filed 2019-02-06 | |||
| 2016-12-31 | $3.00 10-K · filed 2018-02-01 | $16.96 10-K · filed 2019-02-06 | ||
| 2016-09-30 | $4.72 10-K · filed 2018-02-01 | $13.95 10-Q · filed 2017-10-24 | ||
| 2016-06-30 | $4.79 10-K · filed 2018-02-01 | $9.23 10-Q · filed 2017-07-25 | ||
| 2016-03-31 | $4.44 10-K · filed 2018-02-01 | |||
| 2015-12-31 | $3.77 10-K · filed 2017-02-02 | $15.38 10-K · filed 2018-02-01 | ||
| 2015-09-30 | $4.16 10-K · filed 2017-02-02 | $11.60 10-Q · filed 2016-10-26 | ||
| 2015-06-30 | $3.94 10-K · filed 2017-02-02 | $7.44 10-Q · filed 2016-07-21 | ||
| 2015-03-31 | $3.50 10-K · filed 2017-02-02 | |||
| 2014-12-31 | $3.75 10-K · filed 2016-02-03 | $12.42 10-K · filed 2017-02-02 | ||
| 2014-09-30 | $3.63 10-K · filed 2016-02-03 | $8.67 10-Q · filed 2015-10-21 | ||
| 2014-06-30 | $3.02 10-K · filed 2016-02-03 | $5.05 10-Q · filed 2015-07-24 | ||
| 2014-03-31 | $2.03 10-K · filed 2016-02-03 | |||
| 2013-12-31 | $1.94 10-K · filed 2015-02-04 | $7.86 10-K · filed 2016-02-03 | ||
| 2013-09-30 | $2.06 10-K · filed 2015-02-04 | $5.93 10-Q · filed 2014-10-22 | ||
| 2013-06-30 | $2.07 10-K · filed 2015-02-04 | $3.87 10-Q · filed 2014-07-23 | ||
| 2013-03-31 | $1.80 10-K · filed 2015-02-04 | |||
| 2012-12-31 | $1.24 10-K · filed 2014-02-06 | $2.92 derived: net income ÷ weighted average shares · filed 2015-02-04 | $4.54 derived: net income ÷ weighted average shares · filed 2015-02-04 | $5.80 10-K · filed 2015-02-04 |
| 2012-09-30 | $1.68 10-K · filed 2014-02-06 | $3.30 derived: net income ÷ weighted average shares · filed 2013-10-28 | $4.56 10-Q · filed 2013-10-28 | $5.80 derived: net income ÷ weighted average shares · filed 2014-02-06 |
| 2012-06-30 | $1.62 10-K · filed 2014-02-06 | $2.88 10-Q · filed 2013-07-25 | $4.12 derived: net income ÷ weighted average shares · filed 2014-02-06 | $5.56 derived: net income ÷ weighted average shares · filed 2014-02-06 |
| 2012-03-31 | $1.26 10-K · filed 2014-02-06 | $2.50 derived: net income ÷ weighted average shares · filed 2014-02-06 | $3.95 derived: net income ÷ weighted average shares · filed 2014-02-06 | $5.14 derived: net income ÷ weighted average shares · filed 2014-02-06 |
| 2011-12-31 | $1.24 10-K · filed 2013-02-05 | $2.69 derived: net income ÷ weighted average shares · filed 2014-02-06 | $3.87 derived: net income ÷ weighted average shares · filed 2014-02-06 | $5.09 10-K · filed 2014-02-06 |
| 2011-09-30 | $1.45 10-K · filed 2013-02-05 | $2.64 derived: net income ÷ weighted average shares · filed 2012-10-25 | $3.85 10-Q · filed 2012-10-25 | $4.86 derived: net income ÷ weighted average shares · filed 2013-02-05 |
| 2011-06-30 | $1.19 10-K · filed 2013-02-05 | $2.40 10-Q · filed 2012-07-24 | $3.41 derived: net income ÷ weighted average shares · filed 2013-02-05 | $4.46 derived: net income ÷ weighted average shares · filed 2013-02-05 |
| 2011-03-31 | $1.22 10-K · filed 2013-02-05 | $2.22 derived: net income ÷ weighted average shares · filed 2013-02-05 | $3.28 derived: net income ÷ weighted average shares · filed 2013-02-05 | $4.40 derived: net income ÷ weighted average shares · filed 2013-02-05 |
| 2010-12-31 | $1.00 10-K · filed 2012-02-03 | $2.06 derived: net income ÷ weighted average shares · filed 2013-02-05 | $3.19 derived: net income ÷ weighted average shares · filed 2013-02-05 | $3.98 10-K · filed 2013-02-05 |
| 2010-09-30 | $1.06 10-K · filed 2012-02-03 | $2.19 derived: net income ÷ weighted average shares · filed 2011-10-28 | $2.98 10-Q · filed 2011-10-28 | $4.06 derived: net income ÷ weighted average shares · filed 2012-02-03 |
| 2010-06-30 | $1.13 10-K · filed 2012-02-03 | $1.92 10-Q · filed 2011-07-26 | $3.00 derived: net income ÷ weighted average shares · filed 2012-02-03 | $3.96 derived: net income ÷ weighted average shares · filed 2012-02-03 |
| 2010-03-31 | $0.80 10-K · filed 2012-02-03 | $1.88 derived: net income ÷ weighted average shares · filed 2012-02-03 | $2.84 derived: net income ÷ weighted average shares · filed 2012-02-03 | $3.33 derived: net income ÷ weighted average shares · filed 2012-02-03 |
| 2009-12-31 | $1.07 10-K · filed 2011-02-04 | $2.03 derived: net income ÷ weighted average shares · filed 2012-02-03 | $2.52 derived: net income ÷ weighted average shares · filed 2012-02-03 | $3.37 10-K · filed 2012-02-03 |
| 2009-09-30 | $0.96 10-K · filed 2011-02-04 | $1.45 derived: net income ÷ weighted average shares · filed 2010-10-26 | $2.30 10-Q · filed 2010-10-26 | |
| 2009-06-30 | $0.49 10-K · filed 2011-02-04 | $1.34 10-Q · filed 2010-07-20 | ||
| 2009-03-31 | $0.85 10-K · filed 2011-02-04 | |||
| 2008-12-31 | $2.67 10-K · filed 2011-02-04 | |||
| 2008-09-30 | $0.71 10-Q · filed 2009-10-21 | $1.97 10-Q · filed 2009-10-21 | ||
| 2008-06-30 | $0.71 10-Q · filed 2009-07-17 | $1.26 10-Q · filed 2009-07-17 | ||
| 2007-12-31 | $2.02 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |